EZH2 and leukemia: In this study, we leveraged a genetic mouse model recapitulating leukemia progression driven by oncogenic cooperation between signaling (NRasG12D) and epigenetic (EZH2) alterations, and performed time-resolved single-cell transcriptomic profiling to interrogate the molecular and cellular changes during leukemia development.